Nanorobotic microgels to control stem cell fate

Developing innovative microgel technology with nanorobotics to enhance stem cell differentiation for improved cardiac regeneration in myocardial infarction patients.

Subsidie
€ 1.500.000
2024

Projectdetails

Introduction

Myocardial infarction continues to claim the lives of millions of people every year, and survivors are often left with severe health issues. Transplanting cardiac cells engineered from human stem cells into the injured heart is a particularly promising approach to repairing damaged cardiac tissue.

Challenges in Stem Cell Therapy

Despite extensive research on stem cell-based therapies, a major limitation is effectively regulating stem cell differentiation. Mechanically training stem cells throughout culture could be a solution, by exploiting their mechanosensitive nature.

Technological Limitations

However, there is currently a lack of technology that can recreate the mechanically dynamic microenvironment of tissue. Therefore, I aim to develop an innovative cell culture technology based on designer microgels and nanorobotics, which will allow control over stem cell differentiation.

Methodology

To achieve this goal, I will:

  1. Package pluripotent stem cells in smart microgels using microfluidics.
  2. Rigorously adjust material properties to ensure culture conditions that simulate the native tissue microenvironment.
  3. Utilize smart microgels with tunable stiffness to improve cardiogenic differentiation in pluripotent stem cells.
  4. Integrate wirelessly controlled nanoactuators to mechanically train stem cells and decipher the relationship between forces and stem cell differentiation.

Team Collaboration

Together with my team, I will develop rapid culture and stimulation methods based on microfluidics to identify the best conditions for stem cell preparation.

Impact on Regenerative Medicine

This multifunctional technology will contribute to achieving efficient cardiac regeneration and has great potential to make a significant impact in regenerative medicine.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.500.000
Totale projectbegroting€ 1.500.000

Tijdlijn

Startdatum1-11-2024
Einddatum31-10-2029
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • TECHNISCHE UNIVERSITAET MUENCHENpenvoerder

Land(en)

Germany

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC COG

3D-assembly of interactive microgels to grow in vitro vascularized, structured, and beating human cardiac tissues in high-throughput

HEARTBEAT aims to create personalized, vascularized millimeter-scale heart tissues using innovative microgel assemblies to enhance stem cell interactions and mimic native environments.

€ 2.969.219
ERC ADG

Restoring anisotropy in living tissues 'in situ'

This project aims to enhance cardiac tissue regeneration by restoring structural anisotropy using ultrasound, improving therapy outcomes through a multidisciplinary and technology-driven approach.

€ 3.056.887
EIC Pathfinder

Engineering a living human Mini-heart and a swimming Bio-robot

The project aims to develop advanced in vitro human cardiac models, including a vascularized mini-heart and a bio-robot, to better assess cardiotoxicity and improve understanding of cardiovascular disease.

€ 4.475.946
ERC ADG

Advanced human models of the heart to understand cardiovascular disease

Heart2Beat aims to develop innovative 3D human cardiac models using microfluidic technology to enhance understanding and treatment of cardiovascular diseases through personalized medicine.

€ 2.500.000